erlotinib hydrochloride has been researched along with phenylacetylene in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (phenylacetylene) | Trials (phenylacetylene) | Recent Studies (post-2010) (phenylacetylene) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 164 | 0 | 72 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosydar, R; Kwiatek, WM; Maciejewska-Prończuk, J; Oćwieja, M; Paluszkiewicz, C; Piergies, N | 1 |
1 other study(ies) available for erlotinib hydrochloride and phenylacetylene
| Article | Year |
|---|---|
Quantitative and qualitative analyses of drug adsorption on silver nanoparticle monolayers: QCM, SERS, and TEIRA nanospectroscopy studies.
Topics: Adsorption; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Metal Nanoparticles; Quartz Crystal Microbalance Techniques; Silver; Spectrum Analysis, Raman | 2023 |